Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP127 (RNA, 7SK small nuclear pseudogene 127) is a processed pseudogene in the human genome that is homologous to the functional RN7SK small nuclear RNA gene. The parent gene, RN7SK, encodes a highly abundant, non-coding small nuclear RNA that is a key component of the 7SK small nuclear ribonucleoprotein (snRNP) complex, which regulates transcription elongation by sequestering and inhibiting the positive transcription elongation factor b (P-TEFb). In contrast, RN7SKP127 is considered an **inactive pseudogene**: it does not produce a functional RNA or protein product and is not known to have any direct biological function or disease association. Consequently, it is **not a drug target, biomarker, or a gene with known therapeutic implications**. **Note:** - **This entry is not a therapeutically relevant target or functional gene**; pseudogenes like RN7SKP127 are generally remnants of gene duplication or retrotransposition events and lack known activity. Most molecular databases (e.g., GeneCards) list RN7SKP127 as a non-functional pseudogene with no directly annotated function, disease role, or drug interactions. - **The RN7SK parent gene** (not the pseudogene) encodes regulatory RNA relevant for transcriptional elongation but is not a direct therapeutic target itself. - Provided information about function, disease roles, and mechanisms of the parent gene **does not apply** to the pseudogene. **Summary:** **RN7SKP127** is a non-coding, inactive pseudogene with no established function or therapeutic relevance. All core therapeutic and biomarker fields are null or not applicable; the entry is included here for completeness and to prevent misinterpretation as a true druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 127 (RN7SKP127).